Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Khuong-Josses MA"'
Autor:
Marie Suzan-Monti, Bruno Spire, Antoine Vilotitch, Rosemary Dray-Spira, Patrick Yeni, Michel Celse, Baptiste Demoulin
Publikováno v:
AIDS and Behavior
AIDS and Behavior, Springer Verlag, 2018, 22 (10), pp.3264-3272. ⟨10.1007/s10461-018-2077-6⟩
AIDS and Behavior, Springer Verlag, 2018, 22 (10), pp.3264-3272. ⟨10.1007/s10461-018-2077-6⟩
International audience; Some of the 12 criminal trials and sentences in France for HIV transmission in 1998-2011 attracted substantial public attention , with a possible negative impact on people living with HIV (PLWH) through reinforced stigma and d
Autor:
Overton ET; University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: eoverton@uabmc.edu., Richmond G; Nova Southeastern University, FL, USA., Rizzardini G; Fatebenefratelli Sacco Hospital, Milan, Italy; School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa., Jaeger H; MVZ Karlsplatz, HIV Research and Clinical Care Centre, Munich, Germany., Orrell C; Desmond Tutu HIV Foundation, University of Cape Town Medical School, Cape Town, South Africa., Nagimova F; Republic Center for the Prevention and Control of AIDS and Infectious Diseases, Russia., Bredeek F; Metropolis Medical, San Francisco, CA, USA., García Deltoro M; General Hospital of Valencia, Valencia, Spain., Swindells S; University of Nebraska Medical Center, Omaha, USA., Andrade-Villanueva JF; Hospital Civil 'Fray Antonio Alcalde', Guadalajara, Mexico., Wong A; Department of Medicine, University of Saskatchewan, Regina, Saskatchewan, Canada., Khuong-Josses MA; CH - Hôpital Delafontaine, Saint-Denis, France., Van Solingen-Ristea R; Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium., van Eygen V; Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium., Crauwels H; Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium., Ford S; GlaxoSmithKline, Research Triangle Park, NC, USA., Talarico C; ViiV Healthcare, Research Triangle Park, NC, USA., Benn P; ViiV Healthcare, Brentford, UK., Wang Y; GlaxoSmithKline, Collegeville, PA, USA., Hudson KJ; ViiV Healthcare, Research Triangle Park, NC, USA., Chounta V; ViiV Healthcare, Brentford, UK., Cutrell A; ViiV Healthcare, Research Triangle Park, NC, USA., Patel P; ViiV Healthcare, Research Triangle Park, NC, USA., Shaefer M; ViiV Healthcare, Research Triangle Park, NC, USA., Margolis DA; ViiV Healthcare, Research Triangle Park, NC, USA., Smith KY; ViiV Healthcare, Research Triangle Park, NC, USA., Vanveggel S; Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium., Spreen W; ViiV Healthcare, Research Triangle Park, NC, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Dec 19; Vol. 396 (10267), pp. 1994-2005. Date of Electronic Publication: 2020 Dec 09.
Autor:
Smith GHR; Maple Leaf Research, Toronto, Ontario, Canada., Henry WK; Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota, USA., Podzamczer D; HIV Unit, Department of Infectious Diseases, Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain., Masiá MDM; Infectious Diseases Unit, Hospital General Universitario de Elche, Elche, Spain., Bettacchi CJ; North Texas Infectious Disease Consultants, Dallas, Texas, USA., Arasteh K; Epimed GmbH, Berlin, Germany., Jaeger H; MVZ Karlsplatz, HIV Research and Clinical Care Centre, Munich, Germany., Khuong-Josses MA; Service Maladies Infectieuses, CHG-Hôpital Delafontaine, Saint Denis, France., Montes-Ramírez ML; HIV Unit, Service of Internal Medicine, Hospital La Paz Institute for Health Research, Madrid, Spain., Stellbrink HJ; ICH Study Center, Hamburg, Germany., Yazdanpanah Y; Infectious Disease Department, Hôpital Bichat Claude Bernard, Paris, France., Richmond GJ; Gary J. Richmond, Fort Lauderdale, Florida, USA., Sutton KC; Clinical Development, ViiV Healthcare, Research Triangle Park, North Carolina, USA., Zhang F; Dev Biostatistics, GlaxoSmithKline, Collegeville, Pennsylvania, USA., McCoig CC; Clinical Development, ViiV Healthcare, Tres Cantos, Spain., St Clair MH; Department of Translational Medical Research, ViiV Healthcare, Research Triangle Park, North Carolina, USA., Vandermeulen K; Medical Department of Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium., Van Solingen-Ristea R; Medical Department of Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium., Smith KY; Global Research and Medical Strategy, ViiV Healthcare, Research Triangle Park, North Carolina, USA., Margolis DA; Clinical Development, ViiV Healthcare, Research Triangle Park, North Carolina, USA., Spreen WR; Medicines Development, ViiV Healthcare, Research Triangle Park, North Carolina, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2021 Aug 25; Vol. 8 (9), pp. ofab439. Date of Electronic Publication: 2021 Aug 25 (Print Publication: 2021).
Autor:
Murray M; Health Analytics and Outcomes Ltd, London, UK., Antela A; Hospital Clínico Universitario, Santiago de Compostela, Spain., Mills A; Southern California Men's Medical Group, West Hollywood, CA, USA., Huang J; GlaxoSmithKline, Mississauga, ON, Canada., Jäger H; MUC Research GmbH, Munich, Germany.; MVZ Karlsplatz, HIV Research and Clinical Care Centre, Munich, Germany., Bernal E; Hospital General Universitario Reina Sofía, Murcia, Spain., Lombaard J; Josha Research, Bloemfontein, South Africa., Katner H; Mercer University Medical School, Macon, GA, USA., Walmsley S; University Health Network, Toronto, ON, Canada., Khuong-Josses MA; Hôpital Delafontaine, Saint-Denis, France., Hudson K; ViiV Healthcare, Research Triangle Park, NC, USA., Dorey D; GlaxoSmithKline, Mississauga, ON, Canada., Griffith S; ViiV Healthcare, Research Triangle Park, NC, USA., Spreen W; ViiV Healthcare, Research Triangle Park, NC, USA., Vanveggel S; Janssen Research & Development, Beerse, Belgium., Shaefer M; ViiV Healthcare, Research Triangle Park, NC, USA., Margolis D; ViiV Healthcare, Research Triangle Park, NC, USA., Chounta V; ViiV Healthcare, 980 Great West Road, Brentford, TW8 9GS, Middlesex, UK. vasiliki.x.chounta@viivhealthcare.com.
Publikováno v:
AIDS and behavior [AIDS Behav] 2020 Dec; Vol. 24 (12), pp. 3533-3544.
Autor:
van Wyk J; Global Medical, ViiV Healthcare, Brentford, United Kingdom., Orkin C; Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, United Kingdom., Rubio R; HIV Unit, Department of Internal Medicine, Hospital Universitario 12 de Octubre, UCM, Madrid, Spain., Bogner J; Division of Infectious Diseases, Munich University Hospital, Med IV, Munich, Germany., Baker D; East Sydney Doctors, Darlinghurst, Sydney, Australia., Khuong-Josses MA; Infectious Disease Unit, CHG-Hôpital Delafontaine, Saint Denis Cedex, France., Parks D; Central West Clinical Research, St Louis, MO., Angelis K; Biostatistics, GlaxoSmithKline, Uxbridge, United Kingdom., Kahl LP; Clinical Development, ViiV Healthcare, Brentford, United Kingdom., Matthews J; Clinical Development, ViiV Healthcare, Research Triangle Park, NC., Wang R; Clinical Virology, ViiV Healthcare, Research Triangle Park, NC., Underwood M; Clinical Virology, ViiV Healthcare, Research Triangle Park, NC., Wynne B; Medicine Development, ViiV Healthcare, Research Triangle Park, NC., Nascimento MC; Clinical Development, ViiV Healthcare, Brentford, United Kingdom., Vandermeulen K; Global Regulatory and Compound Development, Janssen Pharmaceutica NV, Beerse, Belgium; and., Gartland M; Medicine Development, ViiV Healthcare, Research Triangle Park, NC., Smith KY; Research and Development, ViiV Healthcare, Research Triangle Park, NC.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2020 Nov 01; Vol. 85 (3), pp. 325-330.
Autor:
Couffignal C; IAME-UMR 1137, Inserm and University of Paris, Paris, France.; Biostatistics Department, AP-HP, HUPNVS, Paris, France., Papot E; IAME-UMR 1137, Inserm and University of Paris, Paris, France.; Infectious Diseases Clinic, Bichat-Claude Bernard University Hospital, AP-HP, Paris, France., Etienne A; IAME-UMR 1137, Inserm and University of Paris, Paris, France.; Biostatistics Department, AP-HP, HUPNVS, Paris, France., Legac S; Infectious Diseases Clinic, Bichat-Claude Bernard University Hospital, AP-HP, Paris, France.; COREVIH Ile De France Nord, Paris, France., Laouénan C; IAME-UMR 1137, Inserm and University of Paris, Paris, France.; Biostatistics Department, AP-HP, HUPNVS, Paris, France., Beres D; AIDES, Paris, France., Blum L; Infectious Diseases Department, Pontoise Hospital Center, Cergy Pontoise, France., Khuong-Josses MA; Infectious Diseases Department, Delafontaine Hospital, Saint-Denis, France., Lepretre A; HIV-AIDS Clinic, Simone Veil Hospital, Eaubonne, France., Papazian P; Infectious Diseases Clinic, Bichat-Claude Bernard University Hospital, AP-HP, Paris, France.; COREVIH Ile De France Nord, Paris, France., Yazdanpanah Y; IAME-UMR 1137, Inserm and University of Paris, Paris, France.; Infectious Diseases Clinic, Bichat-Claude Bernard University Hospital, AP-HP, Paris, France.; COREVIH Ile De France Nord, Paris, France., Bouvet E; IAME-UMR 1137, Inserm and University of Paris, Paris, France.; Infectious Diseases Clinic, Bichat-Claude Bernard University Hospital, AP-HP, Paris, France.; COREVIH Ile De France Nord, Paris, France.
Publikováno v:
AIDS care [AIDS Care] 2020 Jul; Vol. 32 (7), pp. 811-817. Date of Electronic Publication: 2019 Aug 21.
Autor:
Aboud M; ViiV Healthcare, Brentford, UK., Orkin C; Queen Mary University of London, London, UK., Podzamczer D; IDIBELL-Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain., Bogner JR; Hospital of the University of Munich, Munich, Germany., Baker D; East Sydney Doctors, Darlinghurst, Sydney, NSW, Australia., Khuong-Josses MA; CHG-Hôpital Delafontaine, Saint Denis, France., Parks D; Central West Clinical Research, St Louis, MO, USA., Angelis K; GlaxoSmithKline, Uxbridge, UK., Kahl LP; ViiV Healthcare, Brentford, UK. Electronic address: lesley.p.kahl@viivhealthcare.com., Blair EA; ViiV Healthcare, Research Triangle Park, NC, USA., Adkison K; ViiV Healthcare, Research Triangle Park, NC, USA., Underwood M; ViiV Healthcare, Research Triangle Park, NC, USA., Matthews JE; ViiV Healthcare, Research Triangle Park, NC, USA., Wynne B; ViiV Healthcare, Research Triangle Park, NC, USA., Vandermeulen K; Janssen Pharmaceutica, Beerse, Belgium., Gartland M; ViiV Healthcare, Research Triangle Park, NC, USA., Smith K; ViiV Healthcare, Research Triangle Park, NC, USA.
Publikováno v:
The lancet. HIV [Lancet HIV] 2019 Sep; Vol. 6 (9), pp. e576-e587. Date of Electronic Publication: 2019 Jul 12.
Autor:
de Monteynard LA; Sorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Matheron S; Sorbonne Paris cité, Université Paris Diderot, UMR 1137, Paris, France.; AP-HP, Hôpital Bichat-Claude Bernard, Service des Maladies Infectieuses et Tropicales, Paris, France., Grabar S; Sorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.; Université Paris Descartes, Sorbonne Paris cité, Paris, France.; APHP, Groupe Hospitalier Cochin Broca Hôtel-Dieu, Unité de Biostatistique et Epidémiologie, Paris, France., de Truchis P; AP-HP, Hôpitaux Universitaires Paris-Ile de France-Ouest, Hôpital Raymond-Poincaré, Département de Médecine Aigüe Spécialisée, Garches, France., Gilquin J; AP-HP, Hôpital Hôtel-Dieu, Unité d'immunoinfectiologie, Paris, France., Pavie J; AP-HP, Hôpital Européen Georges Pompidou, Service d'immunologie clinique, Paris, France., Launay O; Université Paris Descartes, Sorbonne Paris cité, Paris, France.; AP-HP, Hôpital Cochin, Paris, France., Meynard JL; AP-HP, Hôpital Saint Antoine, Service des Maladies Infectieuses et Tropicales, Paris, France., Khuong-Josses MA; Centre Hospitalier Saint-Denis, Hôpital Delafontaine, Service des Maladies Infectieuses et Tropicales, Saint-Denis, France., Rey D; Hôpitaux Universitaire Strasbourg, Centre de Soins de l'Infection par le VIH, Strasbourg, France., Mahamat A; Centre Hospitalier Andrée Rosemon, Service des Maladies Infectieuses et Tropicales, Cayenne, France., Dray-Spira R; Sorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Simon A; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de médecine interne, Paris, France., Costagliola D; Sorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Abgrall S; Sorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.; AP-HP, Hôpital Antoine Béclère, Service de Médecine interne/Immunologie clinique, Clamart, France.
Publikováno v:
PloS one [PLoS One] 2018 Oct 31; Vol. 13 (10), pp. e0205385. Date of Electronic Publication: 2018 Oct 31 (Print Publication: 2018).
Autor:
Melliez H; Sorbonne Universités, UPMC Université Paris, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique.; Service Universitaire des Maladies Infectieuses et du Voyageur, Hopital Gustave Dron, Tourcoing., Mary-Krause M; Sorbonne Universités, UPMC Université Paris, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique., Bocket L; Centre de Pathologies-Biologie, Centre Hospitalier Regional et Universitaire, Lille., Guiguet M; Sorbonne Universités, UPMC Université Paris, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique., Abgrall S; Sorbonne Universités, UPMC Université Paris, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique.; Service de Médecine Interne et Immunologie Clinique, Hôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris (AP-HP), Clamart., De Truchis P; Unité d'Infectiologie, Hôpital Raymond Poincaré, AP-HP, Garches., Katlama C; Sorbonne Universités, UPMC Université Paris, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique.; Département des Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière, AP-HP, Paris., Martin-Blondel G; Service des Maladies Infectieuses et Tropicales, CHU de Toulouse.; Centre de Physiopathologie de Toulouse Purpan, INSERM UMR., Henn A; Service d'Immunologie Clinique et Maladies Infectieuses, Hôpital Henri Mondor, AP-HP, Créteil., Revest M; Service de Maladies Infectieuses et Réanimation Médicale, Hôpital Pontchaillou, Rennes., Robineau O; Service Universitaire des Maladies Infectieuses et du Voyageur, Hopital Gustave Dron, Tourcoing., Khuong-Josses MA; Service de Maladies Infectieuses et Tropicales, Hôpital Delafontaine, Saint-Denis., Canestri A; Service des Maladies infectieuses et tropicales, Hôpital Tenon., De Castro N; Hôpital Saint-Louis., Joly V; Hôpital Bichat, Service des Maladies Infectieuses et Tropicales, AP-HP, Paris., Mokhtari S; Service des Maladies Infectieuses et Tropicales, Hôpital Nord, Marseille., Risso K; Service d'Infectiologie, Hôpital de l'Archet, Nice., Gasnault J; Service de Médecine Interne, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France., Costagliola D; Sorbonne Universités, UPMC Université Paris, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2018 Jul 02; Vol. 67 (2), pp. 275-282.
Autor:
de Monteynard LA; Authors affiliations are listed in the Acknowledgments. †A complete list of contributors appears in the Acknowledgements section., Matheron S, Gilquin J, Pavie J, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Simon A, Mahamat A, Dray-Spira R, Costagliola D, Abgrall S
Publikováno v:
AIDS (London, England) [AIDS] 2016 Sep 10; Vol. 30 (14), pp. 2235-46.